Finance

Lists
4582:TYO
Symbio Pharmaceuticals Ltd
56,00 JP¥
+1,82%
(+1,00) 1D
6 қаз., 09:28:06 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4582...
Open
57 JP¥
High
57 JP¥
Low
56 JP¥
Mkt. cap
4,73 млрд
Avg. vol.
730,92 м.
Volume
274,40 м.
52-wk high
229 JP¥
52-wk low
53 JP¥
EPS
-98 JP¥
Shares outstanding
82,40 млн
No. of employees
91
Open
57 JP¥
High
57 JP¥
Low
56 JP¥
Mkt. cap
4,73 млрд
Avg. vol.
730,92 м.
Volume
274,40 м.
52-wk high
229 JP¥
52-wk low
53 JP¥
EPS
-98 JP¥
Shares outstanding
82,40 млн
No. of employees
91
News stories
From web sources and news partners
About Symbio Pharmaceuticals Ltd
CEO-
Employees91
Founded2005 ж. 25 нау.
HeadquartersMinato City, Токио, Жапония
SectorPharmaceutical industry
Websitesymbiopharma.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
324,17 млн
336,19 млн
233,46 млн
235,54 млн
Cost of goods sold
122,29 млн
84,64 млн
60,63 млн
71,37 млн
Cost of revenue
122,29 млн
84,64 млн
60,63 млн
71,37 млн
Research and development expenses
868,70 млн
846,40 млн
1,99 млрд
-1,99 млрд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
518,54 млн
506,73 млн
522,11 млн
3,45 млрд
Operating expense
1,39 млрд
1,35 млрд
2,51 млрд
1,46 млрд
Total operating expenses
1,51 млрд
1,44 млрд
2,57 млрд
1,53 млрд
Operating income
-1,19 млрд
-1,10 млрд
-2,34 млрд
-1,29 млрд
Other non operating income
-1,57 млн
14,49 млн
-6,26 млн
85,26 млн
EBT including unusual items
-1,20 млрд
-1,19 млрд
-2,39 млрд
-1,21 млрд
EBT excluding unusual items
-1,20 млрд
-1,09 млрд
-2,39 млрд
-1,22 млрд
Income tax expense
-3,66 млн
18,88 млн
13,97 млн
4,03 млн
Effective tax rate
0,30%
-1,58%
-0,58%
-0,33%
Other operating expenses
-
-
-
-
Net income
-1,20 млрд
-1,21 млрд
-2,40 млрд
-1,22 млрд
Net profit margin
-369,09%
-360,02%
-1 028,60%
-516,94%
Earnings per share
-
-
-
-
Interest and investment income
1,73 млн
653,00 м.
2,25 млн
-
Interest expense
-29,04 млн
-11,12 млн
-16,63 млн
-16,62 млн
Net interest expenses
-27,31 млн
-10,47 млн
-14,38 млн
-16,62 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары